795 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Tuesday’s Close
AMGN Amgen Inc. $200.81 $129.98B N/A
Article Searches
Which Big Biotech Has the Safer Dividend -- Amgen or Gilead Sciences? https://www.fool.com/investing/2020/01/26/which-big-biotech-has-the-safer-dividend-amgen-or.aspx?source=iedfolrf0000001 Jan 26, 2020 - Both biotechs claim attractive dividends. But one dividend appears to be at least a little safer than the other.
What Lies Ahead for Healthcare ETFs in Q4 Earnings? http://www.zacks.com/stock/news/731805/what-lies-ahead-for-healthcare-etfs-in-q4-earnings?cid=CS-ZC-FT-etf_news_and_commentary-731805 Jan 24, 2020 - With earnings surprise in the cards, the healthcare sector is expected to witness substantial earnings growth of 4.4% in the fourth quarter, suggesting some room for potential upside for healthcare ETFs.
Will Pfizer's (PFE) BioPharma Unit Boost Its Q4 Earnings? http://www.zacks.com/stock/news/731666/will-pfizers-pfe-biopharma-unit-boost-its-q4-earnings?cid=CS-ZC-FT-analyst_blog|earnings_preview-731666 Jan 24, 2020 - Higher sales of Pfizer's (PFE) key brands, Eliquis, Xeljanz, Ibrance in the Biopharma segment are likely to have made up for lower sales in the Upjohn group.
Amgen (AMGN) Reports Next Week: Wall Street Expects Earnings Growth http://www.zacks.com/stock/news/730796/amgen-amgn-reports-next-week-wall-street-expects-earnings-growth?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_9-730796 Jan 23, 2020 - Amgen (AMGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
5 Big Drug/Biotech Stocks Set to Trump Q4 Earnings Estimates http://www.zacks.com/stock/news/729100/5-big-drug-biotech-stocks-set-to-trump-q4-earnings-estimates?cid=CS-ZC-FT-earnings_esp-729100 Jan 22, 2020 - Let us take a look at some drug/biotech stocks that are poised to beat on earnings in the fourth quarter.
Top Stock Reports for Alphabet, JPMorgan & Comcast http://www.zacks.com/research-daily/726570/top-stock-reports-for-alphabet-jpmorgan-comcast?cid=CS-ZC-FT-research_daily-726570 Jan 20, 2020 - Top Stock Reports for Alphabet, JPMorgan & Comcast
Amgen Inc. (AMGN) CEO Bob Bradway Presents at 38th Annual J.P. Morgan Healthcare Conference Call (Transcript) https://seekingalpha.com/article/4316911-amgen-inc-amgn-ceo-bob-bradway-presents-38th-annual-j-p-morgan-healthcare-conference-call?source=feed_sector_transcripts Jan 14, 2020 -
Biogen Acquires Early-Stage CNS Drug From Pfizer for $75M http://www.zacks.com/stock/news/717331/biogen-acquires-early-stage-cns-drug-from-pfizer-for-%2475m?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-717331 Jan 14, 2020 - Biogen (BIIB) signs deals with Pfizer to acquire rights to a CNS candidate and develop it as potential therapy to treat certain symptoms/disorders related to Alzheimer's disease and Parkinson's disease.
Know These 3 Facts to Avoid Paying Half Your Retirement Income to the IRS - January 13, 2020 http://www.zacks.com/stock/news/715571/know-these-3-facts-to-avoid-paying-half-your-retirement-income-to-the-irs-january-13-2020?cid=CS-ZC-FT-retirement_ideas|required_minimum_distribution-715571 Jan 13, 2020 - Like many investors, you're likely aiming to build a comfortable nest egg to ensure a comfortable retirement. Make sure you know all about what financial planners dub the accumulation and distribution phases of retirement planning.
Merck's Keytruda Gets FDA Nod for High-Risk Bladder Cancer http://www.zacks.com/stock/news/709625/mercks-keytruda-gets-fda-nod-for-high-risk-bladder-cancer?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-709625 Jan 09, 2020 - Merck's (MRK) Keytruda gets FDA's approval to treat certain patients with high-risk, non-muscle invasive bladder cancer.

Pages: 123456...80

Page 1>